Hicksville reported $459,103 in 2024 Medicaid claims for COVID-19-coded services

Dr. Mehmet Oz CMS Administrator
Dr. Mehmet Oz CMS Administrator
0Comments

Data from the U.S. Department of Health and Human Services Medicaid Provider Spending database show that at least $459,103 in Medicaid payments for 2024 in Hicksville were tied to HCPCS codes specifically linked to COVID-19.

Medicaid is a state-administered public health insurance program, financed through a partnership of state and federal governments. It serves low-income individuals and families, children, seniors, and people with disabilities, positioning it as one of the largest elements of the U.S. health care system.

Because taxpayer funds support Medicaid, shifts in local billing levels reveal how public health care resources are distributed in a given community.

This report identified COVID-19–related services using HCPCS codes marked as “COVID-19” or “coronavirus” in billing details or established reference data. The totals reflect only those services that were specifically coded as COVID-related in billing records, excluding other pandemic-associated care billed under general or different codes.

To provide comparison, Brooklyn led all New York locations in Medicaid funds billed for COVID-19 services in 2024, with $3,718,101 in related claims.

In Hicksville, four providers filed Medicaid claims for COVID-19–related services in 2024. The most frequently billed code, COVID Specific, accounted for $451,283 of the total.

On average, each provider in Hicksville billed $114,776 for COVID-19–related Medicaid services, a figure higher than the statewide average of $29,403.

Throughout the pandemic years, services specifically coded for COVID-19 contributed significantly to the rise in Medicaid spending in Hicksville.

Medicaid disbursements for categories other than COVID-19 rose by $46,746,129 from 2020 through 2024, an increase of 113.8%.

In the two years leading up to the pandemic period, Hicksville averaged $32,758,457 annually in Medicaid payments.

According to the Centers for Medicare & Medicaid Services, joint federal and state Medicaid expenditures reached about $871.7 billion in fiscal year 2023, roughly 18% of total national health spending—a significant rise from $613.5 billion in 2019, before the pandemic.

This jump represents an approximate 40% increase over several years, largely fueled by expanded member enrollment and greater utilization during and following the pandemic.

Under recent federal budget measures during the Trump administration, there have been major plans to cut federal Medicaid funding and overhaul the program. The “One Big Beautiful Bill Act,” enacted in 2025, is slated to reduce federal Medicaid spending by more than $1 trillion over 10 years and introduces work requirements and higher cost-sharing, which may result in decreased coverage and funding for certain recipients. These policies are likely to transfer additional costs to states and limit federal Medicaid funding growth, even as the program continues to serve many millions of people.

Medicaid Payments in Hicksville Over 7 Years
Year COVID-19–Related Payments COVID-19 Payments % Change (YoY) Total Medicaid Payments
2024 $459,103 -81.5% $88,290,245
2023 $2,484,085 -77.3% $86,337,716
2022 $10,961,627 -33.7% $80,174,252
2021 $16,543,743 35.8% $66,956,338
2020 $12,185,289 N/A $53,270,303
2019 $0 N/A $35,067,264
2018 $0 N/A $30,449,651
Top COVID-19–Related HCPCS Codes in Hicksville
HCPCS Code Description Medicaid Payments Claims
87635 COVID Specific $451,283 19,316
86769 Immunoassay $7,483 312
90480 COVID-19 Vaccine Administration $337 29

Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.

Information for this report comes from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The original source data is available here.



Related

Sean R. Keveney J.D., Chief Counsel of FDA

FDA inspects Swadesh Board USA, Inc. in Farmingdale on March 20, issues citation

On March 20, the FDA conducted an inspection at Swadesh Board USA, Inc. in Farmingdale for foodborne biological hazards and issued one violation.

Benjamin D. Moncarz Chief Financial Officer - FDA

FDA: 2 companies in cities within Nassau County received 4 citations in March

There were two companies in a city associated with Nassau County that received FDA citations as a result of two inspections conducted in the county in March, according to reports from the U.S. Food and Drug Administration (FDA).

Sara Brenner, Principal Deputy Commissioner at FDA

Swadesh Board USA, Inc. in Farmingdale inspected by FDA for biological hazards March 20

FDA records show that Swadesh Board USA, Inc. in Farmingdale underwent a March 20 inspection related to foodborne biological hazards.